Skip to main content

Halozyme Therapeutics, Inc. - Common Stock (NQ: HALO )

55.94 +1.14 (+2.08%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 21, 2025 Add to My Watchlist

Insider Filings

Form 4
Source: SEC/Edgar
December 03, 2007
Form 4
Source: SEC/Edgar
November 20, 2007
Form 4
Source: SEC/Edgar
November 20, 2007
Form 4
Source: SEC/Edgar
November 20, 2007
Form 3
Source: SEC/Edgar
November 12, 2007
Form 4
Source: SEC/Edgar
November 12, 2007
Form 4
Source: SEC/Edgar
November 12, 2007
Form 4
Source: SEC/Edgar
November 01, 2007
Form 4
Source: SEC/Edgar
October 25, 2007
Form 4
Source: SEC/Edgar
October 25, 2007
Form 4
Source: SEC/Edgar
October 17, 2007
Form 4
Source: SEC/Edgar
October 15, 2007
Form 4
Source: SEC/Edgar
October 10, 2007
Form 4
Source: SEC/Edgar
October 01, 2007
Form 4
Source: SEC/Edgar
October 01, 2007
Form 4
Source: SEC/Edgar
September 27, 2007
Form 4
Source: SEC/Edgar
September 27, 2007
Form 4
Source: SEC/Edgar
September 27, 2007
Form 4
Source: SEC/Edgar
September 25, 2007
Form 4
Source: SEC/Edgar
September 19, 2007
Form 4
Source: SEC/Edgar
September 18, 2007
Form 4
Source: SEC/Edgar
September 16, 2007
Form 4
Source: SEC/Edgar
August 30, 2007
Form 4
Source: SEC/Edgar
August 30, 2007
Form 4
Source: SEC/Edgar
August 30, 2007
Form 4
Source: SEC/Edgar
August 30, 2007
Form 4/A
Source: SEC/Edgar
August 06, 2007
Form 4
Source: SEC/Edgar
August 06, 2007
Form 4
Source: SEC/Edgar
August 02, 2007
Form 4
Source: SEC/Edgar
August 02, 2007
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.